PROM1 and glioma: Purified normal peripheral blood mononuclear cells (PBMC) from glioma patients and K562 cells were used in the test and it demonstrated that less killing occurred in normal PBMC or K562 cells, whereas CTL kill glioma CD133+ CSCs (Figure 8g).